Louw VJ, Fraser I, Giraldo P (2023) Management goals of type 1 Gaucher disease in South Africa: An expert Delphi consensus document on good clinical practice. PLoS ONE 18(8): e0290401. https://doi.org/10.1371/journal.pone.0290401

Sindeep Bhana, Ebrahim Variava, Tinashe V. Mhazo, Janetta C. de Beer, Poobalan Naidoo, Somasundrum Pillay, Michelle Carrihill, Kiolan Naidoo, Luzaan van Wyk, Bruno Pauly. Healthcare Resource Utilization in Controlled Versus Uncontrolled Adults Living With Type 1 Diabetes in the South African Public Healthcare Sector. Value in Health Regional Issues, Volume 36, July 2023, Pages 66-75     https://doi.org/10.1016/j.vhri.2023.03.002  (https://www.sciencedirect.com/science/article/pii/S2212109923000304)

Janetta Catharina de Beer, Jacques Snyman, James Ker, Helen Miller-Janson, Marthinus Stander, Budget Impact Analysis of Empagliflozin in the Treatment of Patients With Type 2 Diabetes With Established Cardiovascular Disease in South Africa, Value in Health Regional Issues, Volume 33, 2023, Pages 91-98. ISSN 2212-1099, https://doi.org/10.1016/j.vhri.2022.08.012

Elbashir, Haitham et al. ‘Gene Therapy for Duchenne Muscular Dystrophy: Unlocking the Opportunities in Countries in the Middle East and Beyond’. Pre-press : 1 – 15. 2022 

Janetta Catharina de Beer, Daisuke Goto, Helen Miller-Janson, Ryan Holl, Goran Bencina;  Vaccine financing in the Middle East and Africa: An overview from 2010 to 2019 

Nelly Ziade, Ihsane Hmamouchi, Lina el Kibbi, Melissa Daou, Nizar Abdulateef, Fatemah Abutiban, Bassel Elzorkany, Chafia Dahou Makhloufi, Wafa Hamdi, Samar Al Emadi, Hussein Halabi, Khalid A. Alnaqbi, Sima Abu Al Saoud, Soad Hashad, Radouane Niamane, Manal El Rakawi, Layla Kazkaz, Sahar Saad, Mervat Eissa, Ilanca Fraser, Basel Masri
Telehealth in rheumatology: the 2021 Arab League of Rheumatology Best Practice Guidelines. Rheumatology International. https://doi.org/10.1007/s00296-021-05078-w

Maryke Wilkinson, Andrew Lofts Gray, Roger Wiseman, Tamara Kredo, Karen Cohen, Jacqui Miot, Mark Blecher, Paul Ruff, Yasmina Johnson, Mladen Poluta, Shelly McGee, Trudy D Leong, Mark Brand, Fatima Suleman, Esnath Maramba, Marc Blockman, Janine Jugathpal, Susan Cleary, Noluthando Nematswerani, Sarvashni Moodliar, Andy Parrish, Khadija K Jamaloodien, Tienie Stander, Kim MacQuilkan, Nicholas Crisp, Thomas Wilkinson. Health Technology Assessment in Support of National Health Insurance in South Africa Volume 38, Issue 1,2022 e44 DOI: https://doi.org/10.1017/S0266462322000265

Feldman C, Dlamini SK, Madhi SA, Meiring S, von Gottberg A, de Beer JC, et al. (2020) The cost-effectiveness of using pneumococcal conjugate vaccine (PCV13) versus pneumococcal polysaccharide vaccine (PPSV23), in South African adults. PLoS ONE 15(1): e0227945. https://doi.org/10.1371/journal.pone.0227945

de Necker M, de Beer JC, Marais T (2019) Public health and economic impact of meningococcal conjugate (MCV4) vaccination in the South African HIV-positive population. Southern African Journal of Public Health (incorporating Strengthening Health Systems) 2019;3(4):61-65. DOI:10.7196/SHS.2019.v3i4.89

Dreyer G, Maske C, Stander M (2019) Clinical evaluation and budget impact analysis of cervical cancer screening using cobas 4800 HPV screening technology in the public sector of South Africa. PLoS ONE 14(9): e0221495. https://doi.org/10.1371/journal.pone.0221495

de Necker M, de Beer JC, Stander MP, Connell CD, Mwai D (2019) Economic and public health impact of decentralized HIV viral load testing: A modelling study in Kenya. PLoS ONE 14(2): e0212972. https://doi.org/10.1371/journal.pone.0212972

MP Stander. How important is Real World Evidence in building your competitive late phase portfolio of evidence. African Journal of Clinical and Outcomes Research 2017 Volume 01. Issue 01

BL Rapoport et al. Ipilimumab in Pretreated Patients with Advanced Malignant Melanoma: Results of the South African Expanded-Access Program. DOI: 10.1200/JGO.2016.006544 Journal of Global Oncology 3, no. 5 (October 01, 2017) 515-523.

Stander, Marthinus P, Bergh, Margreet, Miller-Janson, Helen Elizabeth, Beer, Janetta C. De, & Korb, Frans A. (2016). Depression in the South African workplace. South African Journal of Psychiatry, 22(1), 1-2. https://dx.doi.org/10.4102/sajpsychiatry.v22i1.814

Stander MP, Korb FA, De Necker M, De Beer JC, Miller-Janson HE, et al. (2016) Depression and the Impact on Productivity in the Workplace: Findings from a South African Survey on Depression in the Workplace. J Depress Anxiety S2:012. doi:10.4172/2167-1044.S2-012.

Ilanca Fraser, Johanita Burger, Martie Lubbe, George Dranitsaris, Mark Sonderup, Tienie Stander. Cost effectiveness modelling of Sofosbuvir – containing Regimens for Chronic Genotype 5 Hepatitis C Virus Infection in South Africa. PharmacoEconomics (2016) 34: 403. https://doi.org/10.1007/s40273-015-0356-x

Xiao Li, Martinus P Stander, Georges van Kriekinge, Nadia Demarteau. Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence. BioMed Central Infectious diseases (2015) 15:566. doi: 10.1186/s12879-015-1295-z

De Beer JC, Liebenberg L. Does cancer risk increase with HbA1c, independent of diabetes?2014 Apr 29;110(9):2361-8. doi: 10.1038/bjc.2014.15

MP Stander, HE Miller-Janson, M Bergh, R Pienaar. Cost-effectiveness of lapatinib in metastatic breast cancer: a middle-income perspective. Value in Health, May 2013 16(3):A143. DOI: 10.1016/j.jval.2013.03.701.

MP Stander, M Bergh, H Miller-Janson. A first step towards transparency inpricing of medicines and scheduled substances – publication of guidelines for pharmaco-economic submissions. S Afr Med J, 2013 DOI:10.7196/SAMJ.7284.

M. Bergh, CA Marais, H Miller-Janson, F Salie, MP Stander. Economic appraisal of dabigatran as first-line therapy for stroke prevention in atrial fibrillation. S Afr Med J, April 2013. 2013; 103(4):241-5. DOI: 10.7196/samj.6471.

Stander MP. ISPOR BOOK: Reliability and Validity of Data Sources for Disease and Health Management. South African chapter. 

Brian Williams, Robin wood, victor Dukay, Wim Delva, David Ginsburg, John Hargrove, Martinus Stander, Robert Sheneberger, julio Montaner, Alex Welte. Treatment as prevention: preparing the way. Journal of the International AIDS Society 2011, 14 (Suppl 1) :S6. doi: 10.1186/1758-2652-14-S1-S6.

Alex Welte, John Hargrove, Wim Delva, Brian Williams, Tienie Stander. How different are the costs and consequences of delayed versus immediate HIV treatment? SAMJ June 2011, Vol 101, No.6

Miller-Janson H, Stander MP. Cost-benefit analysis of regional procured essential medicines in SADC with a focus on access to ARVs; presented at the 5^th Southern African AIDS Conference, June 2011, South Africa and poster presented at the 14^th European ISPOR Conference, November 2011 in Spain and published in Value for Health, 2011.  

Wolvaard G, Van Niftrik J, Beira B, Mapham W, Stander MP. The Role of Private and other non-governmental organizations in primary health care.  Chapter 15, South African Health Review 2008.

De Beer J, De Necker M. Economic and Public Health Impact of decentralised HIV Viral Load Testing in Kenya. ISPOR South African Chapter Congress 2018. Poster presentation.

M De Necker, JC De Beer. Impact of burden of disease and cost utility of introducing a meningococcal conjugate vaccination programme in the public sector HIV positive population in South Africa. ISPOR South Africa Chapter congress 2018. Poster presentation

Dreyer, G, Maske, C, Stander, T, De Necker, M, Connell, C. Economic appraisal: clinical evaluation and budget impact analysis of cervical cancer screening using Cobas® hpv screening technology in South Africa. ISPOR South Africa Chapter Congress 2017. Poster Presentation.

Mathijs, S, Dippenaar, J, Greeff, O, Van Tonder, J, Connell, C. Comparison of injection site reactions elicited by two subcutaneous injected heparins, nadroparin calcium and enoxaparin sodium. ISPOR South Africa Chapter Congress 2017. Poster Presentation.

IC Louw et al. Retention of use and safety of subcutaneous abatacept in rheumatoid arthritis: A patient record assessment in a compassionate use programme in South Africa, a tuberculosis endemic country. ACR Annual Scientific Meeting; November 11–16, 2016; Washington, DC, United States.

M de Necker, JC de Beer, C Feldman on behalf of the participants in the Delphi panel. Economic evaluation of 13-valent pneumococcal conjugate vaccine (PCV13) in South African adults in the private healthcare sector. ISPOR South Africa Chapter Congress 2016. Poster Presentation.

Fraser, Ilanca, De Necker, Margreet, Stander, Tienie. Pharmacoeconomic modelling for policy decision-making: the case of sofosbuvir for hepatitis C infection in South Africa. ISPOR South Africa Chapter Congress 2016. Poster Presentation.

M de Necker, JC de Beer, H Miller-Janson, T Stander. Impact of Depression in the South African Workplace. ISPOR South Africa Chapter Congress 2016. Poster Presentation.

Stander MP, Marais C, Miller-Janson H, Bergh M, Wood R, Hargrove JW, Williams BG. Public health and economic consequences of point-of-care CD4 testing in South Africa. ISPOR South Africa Chapter Congress 2016. Poster Presentation.

M de Necker, J de Beer, T Stander. Economic and public health impact of point-of-care HIV viral load testing in three countries. ISPOR South Africa Chapter Congress 2016. Poster Presentation.

Bernardo L. Rapoport, Daniel A. Vorobiof, Lydia M. Dreosti, Adam Nosworthy, Georgina McAdam, Johan P. Jordaan, Hennie Duvenhage, Helen Miller-Jansön, Janina de Beer, Margreet de Necker. Ipilimumab for the treatment of advanced malignant melanoma in pre-treated patients. ISPOR South Africa Chapter Congress 2016. Poster Presentation.

Stander M; Miller-Janson H; Bergh M, Pienaar R. Cost-effectiveness of lapatinib in Metastatic Breast Cancer: a middle-income perspective; presented at the 18^th International ISPOR congress, May 2013, USA. 

Miller-Janson H, Stander MP. Cost-benefit analysis of regional procured essential medicines in SADC with a focus on access to ARVs; presented at the 5^th Southern African AIDS Conference, June 2011, South Africa and poster presented at the 14^th European ISPOR Conference, November 2011 in Spain and published in Value for Health, 2011.  

Marais C, Cooke R, Stander MP, Conradie F, Williams B. Cost Effectiveness of substituting zidovudine with tenofovir in South Africa, Accepted for Poster Presentation at AIDS 2010 Conference, July 2010, Vienna.

Stander MP, Scheijbner HWKFH, Strydom GD, Strutton DR, Farkouh R, Earnshaw SR. Clinical and Economic Benefits of National Immunization with 13-Valent Compared to 7- and 10-Valent Pneumococcal Vaccines in South Africa. Accepted for poster presentation at 7th International Symposium on Pneumococci and Pneumococcal Diseases, Tel Aviv, Israel, March 14-18, 2010.

Marais C, Cooke R, Stander MP, Conradie F, Williams B. Cost Effectiveness of substituting stavudine with tenofivir in South Africa, Accepted for Poster Presentation at CROI 2010, February 2010, San Francisco.

Stander MP, Marais C, Cooke R, Fourie S, Ruff P, Pienaar R, Mc Adam G, King J. The cost-effectiveness of trastusumab for the treatment of breast cancer in the adjuvant setting in South Africa, Poster presentation, ISPOR South Africa Conference, Johannesburg, 2008